ఈక్విటీ ఫండ్స్ సేకరించిన ఫండ్ డబ్బు వివిధ కంపెనీల ఈక్విటీ మరియు ఈక్విటీ-సంబంధిత సాధనాలలో పెట్టుబడి పెట్టబడుతుంది. ఈక్విటీ ఫండ్లను మితమైన మరియు అధికంగా ఉన్నవారికి దీర్ఘకాలిక పెట్టుబడి ఎంపికగా పరిగణిస్తారుఅపాయకరమైన ఆకలి. ఈక్విటీ ఫండ్లలో వివిధ వర్గాలు ఉన్నాయిపెద్ద క్యాప్ ఫండ్స్,మిడ్ క్యాప్ ఫండ్స్,స్మాల్ క్యాప్ ఫండ్స్,ELSS, మరియు మొదలైనవి. 2019 సంవత్సరంలో, ఈక్విటీ మార్కెట్లలో ఒక పెరుగుదల కనిపించింది, ఈ కారణంగా చాలా ఈక్విటీ ఫండ్ వర్గాలు మంచి పనితీరును కనబరిచాయి. ఈ నిధుల పనితీరు పరిశ్రమ పనితీరు, కంపెనీ పనితీరు, కంపెనీల సంపాదన మరియు లాభాలు, దాని భవిష్యత్ సామర్థ్యాలు మరియు వంటి స్థూల మరియు సూక్ష్మ ఆర్థిక పారామితులపై ఆధారపడి ఉంటుంది. ఎగువ మరియుఉత్తమ ఈక్విటీ ఫండ్స్ 2019 సంవత్సరానికి ఈ క్రింది విధంగా ఉన్నాయి.
Talk to our investment specialist
Fund NAV Net Assets (Cr) 2024 (%) 2023 (%) 2022 (%) 2021 (%) 2020 (%) Motilal Oswal Midcap 30 Fund Growth ₹103.454
↑ 0.12 ₹37,501 57.1 41.7 10.7 55.8 9.3 LIC MF Infrastructure Fund Growth ₹49.6653
↓ -0.05 ₹1,054 47.8 44.4 7.9 46.6 -0.1 Motilal Oswal Long Term Equity Fund Growth ₹51.7788
↓ -0.28 ₹4,515 47.7 37 1.8 32.1 8.8 Motilal Oswal Multicap 35 Fund Growth ₹62.328
↓ -0.08 ₹14,319 45.7 31 -3 15.3 10.3 Invesco India Mid Cap Fund Growth ₹187.85
↓ -0.04 ₹9,320 43.1 34.1 0.5 43.1 24.4 UTI Healthcare Fund Growth ₹290.928
↑ 1.47 ₹1,125 42.9 38.2 -12.3 19.1 67.4 SBI Healthcare Opportunities Fund Growth ₹434.594
↓ -0.65 ₹4,082 42.2 38.2 -6 20.1 65.8 TATA India Pharma & Healthcare Fund Growth ₹30.9015
↑ 0.16 ₹1,325 40.4 36.6 -8 19.1 64.4 IDBI Small Cap Fund Growth ₹29.6231
↓ -0.08 ₹647 40 33.4 2.4 64.7 19 Bandhan Infrastructure Fund Growth ₹48.933
↓ -0.13 ₹1,625 39.3 50.3 1.7 64.8 6.3 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 28 Nov 25 Research Highlights & Commentary of 10 Funds showcased
Commentary Motilal Oswal Midcap 30 Fund LIC MF Infrastructure Fund Motilal Oswal Long Term Equity Fund Motilal Oswal Multicap 35 Fund Invesco India Mid Cap Fund UTI Healthcare Fund SBI Healthcare Opportunities Fund TATA India Pharma & Healthcare Fund IDBI Small Cap Fund Bandhan Infrastructure Fund Point 1 Highest AUM (₹37,501 Cr). Bottom quartile AUM (₹1,054 Cr). Upper mid AUM (₹4,515 Cr). Top quartile AUM (₹14,319 Cr). Upper mid AUM (₹9,320 Cr). Bottom quartile AUM (₹1,125 Cr). Upper mid AUM (₹4,082 Cr). Lower mid AUM (₹1,325 Cr). Bottom quartile AUM (₹647 Cr). Lower mid AUM (₹1,625 Cr). Point 2 Established history (11+ yrs). Established history (17+ yrs). Established history (10+ yrs). Established history (11+ yrs). Established history (18+ yrs). Oldest track record among peers (26 yrs). Established history (20+ yrs). Established history (9+ yrs). Established history (8+ yrs). Established history (14+ yrs). Point 3 Rating: 3★ (upper mid). Not Rated. Not Rated. Top rated. Rating: 2★ (upper mid). Rating: 1★ (lower mid). Rating: 2★ (upper mid). Not Rated. Not Rated. Rating: 5★ (top quartile). Point 4 Risk profile: Moderately High. Risk profile: High. Risk profile: Moderately High. Risk profile: Moderately High. Risk profile: Moderately High. Risk profile: High. Risk profile: High. Risk profile: High. Risk profile: Moderately High. Risk profile: High. Point 5 5Y return: 29.82% (top quartile). 5Y return: 27.98% (upper mid). 5Y return: 22.31% (lower mid). 5Y return: 17.17% (bottom quartile). 5Y return: 25.94% (upper mid). 5Y return: 16.86% (bottom quartile). 5Y return: 18.63% (lower mid). 5Y return: 16.96% (bottom quartile). 5Y return: 24.16% (upper mid). 5Y return: 29.13% (top quartile). Point 6 3Y return: 25.90% (upper mid). 3Y return: 26.63% (top quartile). 3Y return: 23.04% (lower mid). 3Y return: 21.64% (bottom quartile). 3Y return: 27.48% (top quartile). 3Y return: 24.04% (lower mid). 3Y return: 24.16% (upper mid). 3Y return: 22.02% (bottom quartile). 3Y return: 16.12% (bottom quartile). 3Y return: 24.77% (upper mid). Point 7 1Y return: -3.15% (bottom quartile). 1Y return: -2.40% (lower mid). 1Y return: -2.90% (lower mid). 1Y return: 1.67% (upper mid). 1Y return: 12.88% (top quartile). 1Y return: 3.15% (upper mid). 1Y return: 4.22% (top quartile). 1Y return: 3.50% (upper mid). 1Y return: -10.92% (bottom quartile). 1Y return: -5.61% (bottom quartile). Point 8 Alpha: -4.22 (bottom quartile). Alpha: -6.32 (bottom quartile). Alpha: -2.71 (lower mid). Alpha: 0.60 (top quartile). Alpha: 0.00 (upper mid). Alpha: -0.28 (upper mid). Alpha: -0.29 (lower mid). Alpha: 1.68 (top quartile). Alpha: -5.20 (bottom quartile). Alpha: 0.00 (upper mid). Point 9 Sharpe: -0.13 (upper mid). Sharpe: -0.04 (upper mid). Sharpe: -0.08 (upper mid). Sharpe: 0.05 (top quartile). Sharpe: 0.43 (top quartile). Sharpe: -0.18 (lower mid). Sharpe: -0.18 (lower mid). Sharpe: -0.28 (bottom quartile). Sharpe: -0.43 (bottom quartile). Sharpe: -0.31 (bottom quartile). Point 10 Information ratio: 0.20 (upper mid). Information ratio: 0.40 (upper mid). Information ratio: 0.75 (top quartile). Information ratio: 0.57 (top quartile). Information ratio: 0.00 (lower mid). Information ratio: 0.00 (bottom quartile). Information ratio: 0.17 (lower mid). Information ratio: 0.56 (upper mid). Information ratio: -0.79 (bottom quartile). Information ratio: 0.00 (bottom quartile). Motilal Oswal Midcap 30 Fund
LIC MF Infrastructure Fund
Motilal Oswal Long Term Equity Fund
Motilal Oswal Multicap 35 Fund
Invesco India Mid Cap Fund
UTI Healthcare Fund
SBI Healthcare Opportunities Fund
TATA India Pharma & Healthcare Fund
IDBI Small Cap Fund
Bandhan Infrastructure Fund
(Erstwhile Motilal Oswal MOSt Focused Midcap 30 Fund) The investment objective of the Scheme is to achieve long term capital appreciation by investing in a maximum of 30 quality mid-cap companies having long-term competitive advantages and potential for growth. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved. Below is the key information for Motilal Oswal Midcap 30 Fund Returns up to 1 year are on The investment objective of the scheme is to provide long term growth from a portfolio of equity / equity related instruments of companies engaged either directly or indirectly in the infrastructure sector. Research Highlights for LIC MF Infrastructure Fund Below is the key information for LIC MF Infrastructure Fund Returns up to 1 year are on (Erstwhile Motilal Oswal MOSt Focused Long Term Fund) The investment objective of the Scheme is to generate long-term capital appreciation from a diversified portfolio of predominantly equity and equity related instruments. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved. Research Highlights for Motilal Oswal Long Term Equity Fund Below is the key information for Motilal Oswal Long Term Equity Fund Returns up to 1 year are on (Erstwhile Motilal Oswal MOSt Focused Multicap 35 Fund) The investment objective of the Scheme is to achieve long term capital appreciation by primarily investing in a maximum of 35 equity & equity related instruments across sectors and market-capitalization levels.However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved. Research Highlights for Motilal Oswal Multicap 35 Fund Below is the key information for Motilal Oswal Multicap 35 Fund Returns up to 1 year are on The Scheme seeks to provide long term capital appreciation by investing in a portfolio that is predominantly constituted of equity and equity related instruments of mid cap companies. However, there can be no assurance that the funds objectives will be achieved. Research Highlights for Invesco India Mid Cap Fund Below is the key information for Invesco India Mid Cap Fund Returns up to 1 year are on (Erstwhile UTI Pharma & Healthcare Fund) The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors. Research Highlights for UTI Healthcare Fund Below is the key information for UTI Healthcare Fund Returns up to 1 year are on (Erstwhile SBI Pharma Fund) To provide the investors maximum growth opportunity through equity
investments in stocks of growth oriented sectors of the economy. Research Highlights for SBI Healthcare Opportunities Fund Below is the key information for SBI Healthcare Opportunities Fund Returns up to 1 year are on The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns. Research Highlights for TATA India Pharma & Healthcare Fund Below is the key information for TATA India Pharma & Healthcare Fund Returns up to 1 year are on The Investment objective of the Scheme is to provide investors with the opportunities for long-term capital appreciation by investing predominantly in Equity and Equity related instruments of Small Cap companies. However
there can be no assurance that the investment objective under the Scheme will be realized. Research Highlights for IDBI Small Cap Fund Below is the key information for IDBI Small Cap Fund Returns up to 1 year are on The investment objective of the scheme is to seek to generate long-term capital growth through an active diversified portfolio of predominantly equity and equity related instruments of companies that are participating in and benefiting from growth in Indian infrastructure and infrastructural related activities. However, there can be no assurance that the investment objective of the scheme will be realized. Research Highlights for Bandhan Infrastructure Fund Below is the key information for Bandhan Infrastructure Fund Returns up to 1 year are on 1. Motilal Oswal Midcap 30 Fund
Motilal Oswal Midcap 30 Fund
Growth Launch Date 24 Feb 14 NAV (28 Nov 25) ₹103.454 ↑ 0.12 (0.11 %) Net Assets (Cr) ₹37,501 on 31 Oct 25 Category Equity - Mid Cap AMC Motilal Oswal Asset Management Co. Ltd Rating ☆☆☆ Risk Moderately High Expense Ratio 1.56 Sharpe Ratio -0.13 Information Ratio 0.2 Alpha Ratio -4.22 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Oct 20 ₹10,000 31 Oct 21 ₹17,165 31 Oct 22 ₹20,795 31 Oct 23 ₹24,620 31 Oct 24 ₹40,895 31 Oct 25 ₹41,318 Returns for Motilal Oswal Midcap 30 Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 28 Nov 25 Duration Returns 1 Month -0.9% 3 Month 0.9% 6 Month 3.9% 1 Year -3.2% 3 Year 25.9% 5 Year 29.8% 10 Year 15 Year Since launch 22% Historical performance (Yearly) on absolute basis
Year Returns 2024 57.1% 2023 41.7% 2022 10.7% 2021 55.8% 2020 9.3% 2019 9.7% 2018 -12.7% 2017 30.8% 2016 5.2% 2015 16.5% Fund Manager information for Motilal Oswal Midcap 30 Fund
Name Since Tenure Ajay Khandelwal 1 Oct 24 1.08 Yr. Niket Shah 1 Jul 20 5.34 Yr. Rakesh Shetty 22 Nov 22 2.94 Yr. Sunil Sawant 1 Jul 24 1.34 Yr. Data below for Motilal Oswal Midcap 30 Fund as on 31 Oct 25
Equity Sector Allocation
Sector Value Technology 40.62% Consumer Cyclical 22.89% Industrials 12.61% Communication Services 3.47% Financial Services 3.46% Real Estate 2.56% Health Care 1.61% Asset Allocation
Asset Class Value Cash 12.78% Equity 87.22% Top Securities Holdings / Portfolio
Name Holding Value Quantity Persistent Systems Ltd (Technology)
Equity, Since 31 Jan 23 | PERSISTENT9% ₹3,550 Cr 6,000,000 Coforge Ltd (Technology)
Equity, Since 31 Mar 23 | COFORGE9% ₹3,494 Cr 19,650,699
↓ -99,301 One97 Communications Ltd (Technology)
Equity, Since 30 Sep 24 | 5433969% ₹3,258 Cr 25,000,000 Dixon Technologies (India) Ltd (Technology)
Equity, Since 31 Mar 23 | DIXON9% ₹3,254 Cr 2,100,000
↑ 62,479 Eternal Ltd (Consumer Cyclical)
Equity, Since 31 Aug 25 | 5433208% ₹3,178 Cr 100,000,000 Kalyan Jewellers India Ltd (Consumer Cyclical)
Equity, Since 29 Feb 24 | KALYANKJIL8% ₹3,058 Cr 60,000,000 Trent Ltd (Consumer Cyclical)
Equity, Since 30 Nov 24 | 5002516% ₹2,347 Cr 4,999,694 Polycab India Ltd (Industrials)
Equity, Since 30 Sep 23 | POLYCAB5% ₹2,060 Cr 2,673,670
↓ -476,330 Kaynes Technology India Ltd (Technology)
Equity, Since 30 Jun 25 | KAYNES4% ₹1,676 Cr 2,500,000
↑ 150,000 KEI Industries Ltd (Industrials)
Equity, Since 30 Nov 24 | KEI4% ₹1,613 Cr 4,000,000 2. LIC MF Infrastructure Fund
LIC MF Infrastructure Fund
Growth Launch Date 29 Feb 08 NAV (28 Nov 25) ₹49.6653 ↓ -0.05 (-0.11 %) Net Assets (Cr) ₹1,054 on 31 Oct 25 Category Equity - Sectoral AMC LIC Mutual Fund Asset Mgmt Co Ltd Rating Risk High Expense Ratio 2.21 Sharpe Ratio -0.04 Information Ratio 0.4 Alpha Ratio -6.32 Min Investment 5,000 Min SIP Investment 1,000 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Oct 20 ₹10,000 31 Oct 21 ₹16,982 31 Oct 22 ₹18,599 31 Oct 23 ₹23,073 31 Oct 24 ₹39,075 31 Oct 25 ₹39,641 Returns for LIC MF Infrastructure Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 28 Nov 25 Duration Returns 1 Month -1.7% 3 Month 4.5% 6 Month 1.6% 1 Year -2.4% 3 Year 26.6% 5 Year 28% 10 Year 15 Year Since launch 9.5% Historical performance (Yearly) on absolute basis
Year Returns 2024 47.8% 2023 44.4% 2022 7.9% 2021 46.6% 2020 -0.1% 2019 13.3% 2018 -14.6% 2017 42.2% 2016 -2.2% 2015 -6.2% Fund Manager information for LIC MF Infrastructure Fund
Name Since Tenure Yogesh Patil 18 Sep 20 5.12 Yr. Mahesh Bendre 1 Jul 24 1.34 Yr. Data below for LIC MF Infrastructure Fund as on 31 Oct 25
Equity Sector Allocation
Sector Value Industrials 46.67% Basic Materials 10.73% Consumer Cyclical 7.92% Financial Services 7.74% Utility 5.33% Technology 4.46% Real Estate 3.56% Health Care 3.4% Communication Services 3.11% Energy 0.98% Asset Allocation
Asset Class Value Cash 5.56% Equity 94.44% Top Securities Holdings / Portfolio
Name Holding Value Quantity Shakti Pumps (India) Ltd (Industrials)
Equity, Since 31 Mar 24 | SHAKTIPUMP5% ₹57 Cr 693,857 Larsen & Toubro Ltd (Industrials)
Equity, Since 30 Apr 09 | LT4% ₹44 Cr 109,584 Afcons Infrastructure Ltd (Industrials)
Equity, Since 31 Oct 24 | AFCONS3% ₹34 Cr 769,765 REC Ltd (Financial Services)
Equity, Since 31 Jul 23 | 5329553% ₹34 Cr 911,009 Avalon Technologies Ltd (Technology)
Equity, Since 31 Jul 23 | AVALON3% ₹34 Cr 286,134
↓ -24,481 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Jun 25 | APOLLOHOSP3% ₹34 Cr 44,149 Garware Hi-Tech Films Ltd (Basic Materials)
Equity, Since 31 Aug 23 | 5006553% ₹32 Cr 94,287 Bharat Bijlee Ltd (Industrials)
Equity, Since 31 Jul 22 | BBL3% ₹28 Cr 93,633
↑ 13,500 Cummins India Ltd (Industrials)
Equity, Since 31 May 21 | 5004803% ₹27 Cr 62,276 Schneider Electric Infrastructure Ltd (Industrials)
Equity, Since 31 Dec 23 | SCHNEIDER3% ₹27 Cr 319,302 3. Motilal Oswal Long Term Equity Fund
Motilal Oswal Long Term Equity Fund
Growth Launch Date 21 Jan 15 NAV (28 Nov 25) ₹51.7788 ↓ -0.28 (-0.53 %) Net Assets (Cr) ₹4,515 on 31 Oct 25 Category Equity - ELSS AMC Motilal Oswal Asset Management Co. Ltd Rating Risk Moderately High Expense Ratio 1.65 Sharpe Ratio -0.08 Information Ratio 0.75 Alpha Ratio -2.71 Min Investment 500 Min SIP Investment 500 Exit Load NIL Growth of 10,000 investment over the years.
Date Value 31 Oct 20 ₹10,000 31 Oct 21 ₹16,097 31 Oct 22 ₹16,180 31 Oct 23 ₹19,013 31 Oct 24 ₹31,259 31 Oct 25 ₹31,328 Returns for Motilal Oswal Long Term Equity Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 28 Nov 25 Duration Returns 1 Month -2.4% 3 Month 4.3% 6 Month 1.4% 1 Year -2.9% 3 Year 23% 5 Year 22.3% 10 Year 15 Year Since launch 16.4% Historical performance (Yearly) on absolute basis
Year Returns 2024 47.7% 2023 37% 2022 1.8% 2021 32.1% 2020 8.8% 2019 13.2% 2018 -8.7% 2017 44% 2016 12.5% 2015 Fund Manager information for Motilal Oswal Long Term Equity Fund
Name Since Tenure Ajay Khandelwal 11 Dec 23 1.89 Yr. Rakesh Shetty 22 Nov 22 2.94 Yr. Atul Mehra 1 Oct 24 1.08 Yr. Data below for Motilal Oswal Long Term Equity Fund as on 31 Oct 25
Equity Sector Allocation
Sector Value Industrials 28.02% Consumer Cyclical 19.57% Technology 17.86% Financial Services 14.25% Basic Materials 7.64% Real Estate 4.16% Health Care 3.27% Communication Services 1.87% Asset Allocation
Asset Class Value Cash 0.17% Equity 99.83% Top Securities Holdings / Portfolio
Name Holding Value Quantity Eternal Ltd (Consumer Cyclical)
Equity, Since 31 Oct 23 | 5433206% ₹285 Cr 8,970,581 Multi Commodity Exchange of India Ltd (Financial Services)
Equity, Since 29 Feb 24 | MCX5% ₹240 Cr 259,208 Waaree Energies Ltd (Technology)
Equity, Since 31 Oct 24 | 5442774% ₹200 Cr 583,979 Kaynes Technology India Ltd (Technology)
Equity, Since 30 Jun 23 | KAYNES4% ₹194 Cr 289,593 Amber Enterprises India Ltd Ordinary Shares (Consumer Cyclical)
Equity, Since 31 Mar 24 | AMBER4% ₹193 Cr 240,350 Prestige Estates Projects Ltd (Real Estate)
Equity, Since 31 Oct 23 | PRESTIGE4% ₹188 Cr 1,077,437 Muthoot Finance Ltd (Financial Services)
Equity, Since 30 Jun 25 | 5333984% ₹174 Cr 546,874 PTC Industries Ltd (Industrials)
Equity, Since 30 Sep 24 | 5390064% ₹173 Cr 100,321 One97 Communications Ltd (Technology)
Equity, Since 30 Jun 25 | 5433964% ₹164 Cr 1,256,967 Gujarat Fluorochemicals Ltd Ordinary Shares (Basic Materials)
Equity, Since 28 Feb 23 | FLUOROCHEM4% ₹161 Cr 430,073 4. Motilal Oswal Multicap 35 Fund
Motilal Oswal Multicap 35 Fund
Growth Launch Date 28 Apr 14 NAV (28 Nov 25) ₹62.328 ↓ -0.08 (-0.13 %) Net Assets (Cr) ₹14,319 on 31 Oct 25 Category Equity - Multi Cap AMC Motilal Oswal Asset Management Co. Ltd Rating ☆☆☆☆☆ Risk Moderately High Expense Ratio 1.77 Sharpe Ratio 0.05 Information Ratio 0.57 Alpha Ratio 0.6 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Oct 20 ₹10,000 31 Oct 21 ₹13,623 31 Oct 22 ₹13,522 31 Oct 23 ₹15,130 31 Oct 24 ₹23,154 31 Oct 25 ₹24,384 Returns for Motilal Oswal Multicap 35 Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 28 Nov 25 Duration Returns 1 Month -0.6% 3 Month 2% 6 Month 3.7% 1 Year 1.7% 3 Year 21.6% 5 Year 17.2% 10 Year 15 Year Since launch 17.1% Historical performance (Yearly) on absolute basis
Year Returns 2024 45.7% 2023 31% 2022 -3% 2021 15.3% 2020 10.3% 2019 7.9% 2018 -7.8% 2017 43.1% 2016 8.5% 2015 14.6% Fund Manager information for Motilal Oswal Multicap 35 Fund
Name Since Tenure Ajay Khandelwal 1 Oct 24 1.08 Yr. Niket Shah 1 Jul 22 3.34 Yr. Rakesh Shetty 22 Nov 22 2.94 Yr. Atul Mehra 1 Oct 24 1.08 Yr. Sunil Sawant 1 Jul 24 1.34 Yr. Data below for Motilal Oswal Multicap 35 Fund as on 31 Oct 25
Equity Sector Allocation
Sector Value Technology 30.04% Consumer Cyclical 24.62% Industrials 17.86% Financial Services 9.31% Utility 4.45% Communication Services 3.01% Asset Allocation
Asset Class Value Cash 10.72% Equity 89.28% Top Securities Holdings / Portfolio
Name Holding Value Quantity Persistent Systems Ltd (Technology)
Equity, Since 31 Mar 23 | PERSISTENT10% ₹1,440 Cr 2,433,634
↓ -66,366 Eternal Ltd (Consumer Cyclical)
Equity, Since 31 May 25 | 5433209% ₹1,271 Cr 40,000,000 Dixon Technologies (India) Ltd (Technology)
Equity, Since 31 Mar 25 | DIXON9% ₹1,240 Cr 799,993
↑ 18,567 Coforge Ltd (Technology)
Equity, Since 31 May 23 | COFORGE9% ₹1,220 Cr 6,863,878
↓ -1,136,122 Kalyan Jewellers India Ltd (Consumer Cyclical)
Equity, Since 30 Sep 23 | KALYANKJIL8% ₹1,198 Cr 23,500,000
↑ 1,000,000 Polycab India Ltd (Industrials)
Equity, Since 31 Jan 24 | POLYCAB8% ₹1,187 Cr 1,540,612
↓ -345,714 Trent Ltd (Consumer Cyclical)
Equity, Since 31 Jan 23 | 5002517% ₹1,056 Cr 2,250,000
↑ 243,330 Cholamandalam Investment and Finance Co Ltd (Financial Services)
Equity, Since 31 Mar 23 | CHOLAFIN7% ₹997 Cr 5,877,496 CG Power & Industrial Solutions Ltd (Industrials)
Equity, Since 31 Jan 25 | 5000936% ₹884 Cr 12,000,000
↓ -500,000 Siemens Energy India Ltd (Utilities)
Equity, Since 30 Jun 25 | ENRIN4% ₹637 Cr 2,000,000
↓ -171,491 5. Invesco India Mid Cap Fund
Invesco India Mid Cap Fund
Growth Launch Date 19 Apr 07 NAV (28 Nov 25) ₹187.85 ↓ -0.04 (-0.02 %) Net Assets (Cr) ₹9,320 on 31 Oct 25 Category Equity - Mid Cap AMC Invesco Asset Management (India) Private Ltd Rating ☆☆ Risk Moderately High Expense Ratio 1.82 Sharpe Ratio 0.43 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Oct 20 ₹10,000 31 Oct 21 ₹16,521 31 Oct 22 ₹16,892 31 Oct 23 ₹19,784 31 Oct 24 ₹30,612 31 Oct 25 ₹34,834 Returns for Invesco India Mid Cap Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 28 Nov 25 Duration Returns 1 Month 0.7% 3 Month 5.5% 6 Month 12.2% 1 Year 12.9% 3 Year 27.5% 5 Year 25.9% 10 Year 15 Year Since launch 17.1% Historical performance (Yearly) on absolute basis
Year Returns 2024 43.1% 2023 34.1% 2022 0.5% 2021 43.1% 2020 24.4% 2019 3.8% 2018 -5.3% 2017 44.3% 2016 1.1% 2015 6.4% Fund Manager information for Invesco India Mid Cap Fund
Name Since Tenure Aditya Khemani 9 Nov 23 1.98 Yr. Amit Ganatra 1 Sep 23 2.17 Yr. Data below for Invesco India Mid Cap Fund as on 31 Oct 25
Equity Sector Allocation
Sector Value Financial Services 34.12% Health Care 18.22% Consumer Cyclical 17% Industrials 9.12% Real Estate 8.42% Technology 7.23% Basic Materials 3.95% Communication Services 1.39% Asset Allocation
Asset Class Value Cash 0.56% Equity 99.44% Top Securities Holdings / Portfolio
Name Holding Value Quantity AU Small Finance Bank Ltd (Financial Services)
Equity, Since 31 Jul 25 | 5406116% ₹521 Cr 5,936,790 Swiggy Ltd (Consumer Cyclical)
Equity, Since 30 Nov 24 | SWIGGY5% ₹487 Cr 11,879,113
↑ 1,517,109 The Federal Bank Ltd (Financial Services)
Equity, Since 31 Oct 22 | FEDERALBNK5% ₹472 Cr 19,960,984
↑ 5,368,346 L&T Finance Ltd (Financial Services)
Equity, Since 31 Dec 23 | LTF5% ₹456 Cr 16,854,973 Prestige Estates Projects Ltd (Real Estate)
Equity, Since 30 Nov 23 | PRESTIGE5% ₹428 Cr 2,451,815
↑ 33,004 BSE Ltd (Financial Services)
Equity, Since 31 Dec 23 | BSE4% ₹377 Cr 1,519,233 Max Financial Services Ltd (Financial Services)
Equity, Since 30 Nov 23 | 5002714% ₹375 Cr 2,422,867
↑ 324,236 Glenmark Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Mar 24 | 5322964% ₹353 Cr 1,864,031
↑ 187,614 Sai Life Sciences Ltd (Healthcare)
Equity, Since 31 Dec 24 | SAILIFE3% ₹308 Cr 3,351,338
↑ 116,840 JK Cement Ltd (Basic Materials)
Equity, Since 31 Oct 22 | JKCEMENT3% ₹297 Cr 477,753 6. UTI Healthcare Fund
UTI Healthcare Fund
Growth Launch Date 28 Jun 99 NAV (28 Nov 25) ₹290.928 ↑ 1.47 (0.51 %) Net Assets (Cr) ₹1,125 on 31 Oct 25 Category Equity - Sectoral AMC UTI Asset Management Company Ltd Rating ☆ Risk High Expense Ratio 2.26 Sharpe Ratio -0.18 Information Ratio 0 Alpha Ratio -0.28 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Oct 20 ₹10,000 31 Oct 21 ₹12,799 31 Oct 22 ₹12,052 31 Oct 23 ₹14,059 31 Oct 24 ₹22,392 31 Oct 25 ₹22,840 Returns for UTI Healthcare Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 28 Nov 25 Duration Returns 1 Month -0.2% 3 Month 0.6% 6 Month 5.5% 1 Year 3.2% 3 Year 24% 5 Year 16.9% 10 Year 15 Year Since launch 14.8% Historical performance (Yearly) on absolute basis
Year Returns 2024 42.9% 2023 38.2% 2022 -12.3% 2021 19.1% 2020 67.4% 2019 1.2% 2018 -7.5% 2017 6.2% 2016 -9.7% 2015 12.4% Fund Manager information for UTI Healthcare Fund
Name Since Tenure Kamal Gada 2 May 22 3.5 Yr. Data below for UTI Healthcare Fund as on 31 Oct 25
Equity Sector Allocation
Sector Value Health Care 97.05% Basic Materials 1.08% Asset Allocation
Asset Class Value Cash 1.88% Equity 98.12% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMA10% ₹110 Cr 650,000
↓ -11,016 Ajanta Pharma Ltd (Healthcare)
Equity, Since 31 Jul 17 | 5323316% ₹70 Cr 285,000
↑ 35,000 Lupin Ltd (Healthcare)
Equity, Since 28 Feb 25 | 5002576% ₹63 Cr 319,570
↑ 49,570 Glenmark Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Mar 24 | 5322964% ₹46 Cr 245,000
↑ 35,000 Cipla Ltd (Healthcare)
Equity, Since 31 Jan 03 | 5000874% ₹42 Cr 280,000
↓ -120,000 Procter & Gamble Health Ltd (Healthcare)
Equity, Since 31 Dec 20 | PGHL4% ₹41 Cr 67,014
↓ -2,306 Gland Pharma Ltd (Healthcare)
Equity, Since 30 Nov 20 | GLAND4% ₹41 Cr 213,141
↑ 13,844 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Apr 21 | APOLLOHOSP4% ₹41 Cr 53,000 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | DRREDDY4% ₹40 Cr 335,000 Alkem Laboratories Ltd (Healthcare)
Equity, Since 31 May 21 | ALKEM4% ₹40 Cr 72,000 7. SBI Healthcare Opportunities Fund
SBI Healthcare Opportunities Fund
Growth Launch Date 31 Dec 04 NAV (27 Nov 25) ₹434.594 ↓ -0.65 (-0.15 %) Net Assets (Cr) ₹4,082 on 31 Oct 25 Category Equity - Sectoral AMC SBI Funds Management Private Limited Rating ☆☆ Risk High Expense Ratio 1.97 Sharpe Ratio -0.18 Information Ratio 0.17 Alpha Ratio -0.29 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-15 Days (0.5%),15 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Oct 20 ₹10,000 31 Oct 21 ₹12,709 31 Oct 22 ₹12,920 31 Oct 23 ₹15,414 31 Oct 24 ₹24,279 31 Oct 25 ₹24,895 Returns for SBI Healthcare Opportunities Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 28 Nov 25 Duration Returns 1 Month -0.5% 3 Month 0.5% 6 Month 3.9% 1 Year 4.2% 3 Year 24.2% 5 Year 18.6% 10 Year 15 Year Since launch 15.3% Historical performance (Yearly) on absolute basis
Year Returns 2024 42.2% 2023 38.2% 2022 -6% 2021 20.1% 2020 65.8% 2019 -0.5% 2018 -9.9% 2017 2.1% 2016 -14% 2015 27.1% Fund Manager information for SBI Healthcare Opportunities Fund
Name Since Tenure Tanmaya Desai 1 Jun 11 14.43 Yr. Data below for SBI Healthcare Opportunities Fund as on 31 Oct 25
Equity Sector Allocation
Sector Value Health Care 89.67% Basic Materials 6.39% Asset Allocation
Asset Class Value Cash 3.93% Equity 96.07% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Dec 17 | SUNPHARMA11% ₹456 Cr 2,700,000 Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB7% ₹296 Cr 440,000 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Mar 21 | MAXHEALTH6% ₹230 Cr 2,000,000 Cipla Ltd (Healthcare)
Equity, Since 31 Aug 16 | 5000874% ₹180 Cr 1,200,000 Lonza Group Ltd ADR (Healthcare)
Equity, Since 31 Jan 24 | LZAGY4% ₹165 Cr 270,000 Lupin Ltd (Healthcare)
Equity, Since 31 Aug 23 | 5002574% ₹165 Cr 840,000 Acutaas Chemicals Ltd (Basic Materials)
Equity, Since 30 Jun 24 | 5433494% ₹155 Cr 900,000 Fortis Healthcare Ltd (Healthcare)
Equity, Since 30 Apr 21 | 5328434% ₹153 Cr 1,500,000 Torrent Pharmaceuticals Ltd (Healthcare)
Equity, Since 30 Jun 21 | TORNTPHARM3% ₹142 Cr 400,000 Jupiter Life Line Hospitals Ltd (Healthcare)
Equity, Since 31 Aug 23 | JLHL3% ₹141 Cr 890,405
↑ 61,698 8. TATA India Pharma & Healthcare Fund
TATA India Pharma & Healthcare Fund
Growth Launch Date 28 Dec 15 NAV (28 Nov 25) ₹30.9015 ↑ 0.16 (0.52 %) Net Assets (Cr) ₹1,325 on 31 Oct 25 Category Equity - Sectoral AMC Tata Asset Management Limited Rating Risk High Expense Ratio 2.17 Sharpe Ratio -0.28 Information Ratio 0.56 Alpha Ratio 1.68 Min Investment 5,000 Min SIP Investment 150 Exit Load 0-3 Months (0.25%),3 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Oct 20 ₹10,000 31 Oct 21 ₹12,776 31 Oct 22 ₹12,763 31 Oct 23 ₹14,596 31 Oct 24 ₹22,921 31 Oct 25 ₹22,928 Returns for TATA India Pharma & Healthcare Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 28 Nov 25 Duration Returns 1 Month 0.4% 3 Month 1.4% 6 Month 5.7% 1 Year 3.5% 3 Year 22% 5 Year 17% 10 Year 15 Year Since launch 12% Historical performance (Yearly) on absolute basis
Year Returns 2024 40.4% 2023 36.6% 2022 -8% 2021 19.1% 2020 64.4% 2019 5.5% 2018 -2.6% 2017 4.7% 2016 -14.7% 2015 Fund Manager information for TATA India Pharma & Healthcare Fund
Name Since Tenure Rajat Srivastava 16 Sep 24 1.13 Yr. Data below for TATA India Pharma & Healthcare Fund as on 31 Oct 25
Equity Sector Allocation
Sector Value Health Care 96.33% Basic Materials 2.17% Asset Allocation
Asset Class Value Cash 1.5% Equity 98.5% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Jan 16 | SUNPHARMA10% ₹127 Cr 751,703
↓ -63,780 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 31 Dec 16 | APOLLOHOSP5% ₹68 Cr 88,528 HealthCare Global Enterprises Ltd (Healthcare)
Equity, Since 31 Dec 18 | HCG5% ₹66 Cr 880,171
↓ -62,282 Lupin Ltd (Healthcare)
Equity, Since 30 Nov 17 | 5002575% ₹65 Cr 330,887 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Jul 25 | MAXHEALTH5% ₹62 Cr 543,979
↑ 85,255 Torrent Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Aug 22 | TORNTPHARM5% ₹60 Cr 168,394 Alkem Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 20 | ALKEM4% ₹59 Cr 106,435 Abbott India Ltd (Healthcare)
Equity, Since 30 Sep 25 | ABBOTINDIA4% ₹53 Cr 18,387
↑ 5,535 Cipla Ltd (Healthcare)
Equity, Since 30 Apr 20 | 5000874% ₹52 Cr 346,084
↓ -72,784 Ipca Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 16 | 5244944% ₹47 Cr 370,697
↑ 60,605 9. IDBI Small Cap Fund
IDBI Small Cap Fund
Growth Launch Date 21 Jun 17 NAV (28 Nov 25) ₹29.6231 ↓ -0.08 (-0.28 %) Net Assets (Cr) ₹647 on 31 Oct 25 Category Equity - Small Cap AMC IDBI Asset Management Limited Rating Risk Moderately High Expense Ratio 2.3 Sharpe Ratio -0.43 Information Ratio -0.79 Alpha Ratio -5.2 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-12 Months (1%),12 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Oct 20 ₹10,000 31 Oct 21 ₹18,487 31 Oct 22 ₹20,834 31 Oct 23 ₹24,081 31 Oct 24 ₹36,595 31 Oct 25 ₹34,102 Returns for IDBI Small Cap Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 28 Nov 25 Duration Returns 1 Month -2.7% 3 Month 0.9% 6 Month -0.1% 1 Year -10.9% 3 Year 16.1% 5 Year 24.2% 10 Year 15 Year Since launch 13.7% Historical performance (Yearly) on absolute basis
Year Returns 2024 40% 2023 33.4% 2022 2.4% 2021 64.7% 2020 19% 2019 -4.4% 2018 -15% 2017 2016 2015 Fund Manager information for IDBI Small Cap Fund
Name Since Tenure Nikhil Rungta 1 Jul 24 1.33 Yr. Mahesh Bendre 1 Jul 24 1.33 Yr. Data below for IDBI Small Cap Fund as on 31 Oct 25
Equity Sector Allocation
Sector Value Industrials 30.11% Basic Materials 14.97% Consumer Cyclical 14.55% Consumer Defensive 8.55% Technology 7.49% Health Care 7.15% Financial Services 7.05% Utility 6.09% Communication Services 0.9% Real Estate 0.02% Asset Allocation
Asset Class Value Cash 3.11% Equity 96.89% Top Securities Holdings / Portfolio
Name Holding Value Quantity Apollo Micro Systems Ltd Ordinary Shares (Industrials)
Equity, Since 30 Jun 25 | APOLLO3% ₹22 Cr 877,192 Allied Blenders and Distillers Ltd (Consumer Defensive)
Equity, Since 31 Jul 24 | ABDL3% ₹22 Cr 326,140 Avalon Technologies Ltd (Technology)
Equity, Since 31 Aug 23 | AVALON3% ₹16 Cr 135,939
↓ -12,174 Manorama Industries Ltd (Consumer Defensive)
Equity, Since 31 Dec 24 | 5419742% ₹15 Cr 109,106 Syrma SGS Technology Ltd (Technology)
Equity, Since 31 May 25 | SYRMA2% ₹15 Cr 180,780 Navkar Corp Ltd (Industrials)
Equity, Since 31 Jul 24 | NAVKARCORP2% ₹13 Cr 1,130,075 Housing & Urban Development Corp Ltd (Financial Services)
Equity, Since 31 Oct 24 | HUDCO2% ₹13 Cr 557,918 Concord Enviro Systems Ltd (Utilities)
Equity, Since 31 Dec 24 | CEWATER2% ₹13 Cr 270,441 Arvind Fashions Ltd (Consumer Cyclical)
Equity, Since 29 Feb 24 | ARVINDFASN2% ₹13 Cr 259,739 Navin Fluorine International Ltd (Basic Materials)
Equity, Since 30 Sep 19 | NAVINFLUOR2% ₹13 Cr 22,671 10. Bandhan Infrastructure Fund
Bandhan Infrastructure Fund
Growth Launch Date 8 Mar 11 NAV (28 Nov 25) ₹48.933 ↓ -0.13 (-0.26 %) Net Assets (Cr) ₹1,625 on 31 Oct 25 Category Equity - Sectoral AMC IDFC Asset Management Company Limited Rating ☆☆☆☆☆ Risk High Expense Ratio 2.1 Sharpe Ratio -0.31 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 100 Exit Load 0-365 Days (1%),365 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Oct 20 ₹10,000 31 Oct 21 ₹20,050 31 Oct 22 ₹20,377 31 Oct 23 ₹26,163 31 Oct 24 ₹43,146 31 Oct 25 ₹41,438 Returns for Bandhan Infrastructure Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 28 Nov 25 Duration Returns 1 Month -2.3% 3 Month 0.5% 6 Month -3.1% 1 Year -5.6% 3 Year 24.8% 5 Year 29.1% 10 Year 15 Year Since launch 11.4% Historical performance (Yearly) on absolute basis
Year Returns 2024 39.3% 2023 50.3% 2022 1.7% 2021 64.8% 2020 6.3% 2019 -5.3% 2018 -25.9% 2017 58.7% 2016 10.7% 2015 -0.2% Fund Manager information for Bandhan Infrastructure Fund
Name Since Tenure Vishal Biraia 24 Jan 24 1.77 Yr. Ritika Behera 7 Oct 23 2.07 Yr. Gaurav Satra 7 Jun 24 1.4 Yr. Data below for Bandhan Infrastructure Fund as on 31 Oct 25
Equity Sector Allocation
Sector Value Industrials 53.35% Utility 12.64% Basic Materials 8.05% Communication Services 4.41% Energy 4.1% Technology 3.65% Financial Services 2.97% Health Care 2.22% Real Estate 1.44% Consumer Cyclical 1.17% Asset Allocation
Asset Class Value Cash 6.01% Equity 93.99% Top Securities Holdings / Portfolio
Name Holding Value Quantity Larsen & Toubro Ltd (Industrials)
Equity, Since 29 Feb 12 | LT5% ₹82 Cr 204,050
↓ -2,212 Kirloskar Brothers Ltd (Industrials)
Equity, Since 31 Dec 17 | KIRLOSBROS5% ₹80 Cr 426,772
↓ -6,414 Bharti Airtel Ltd (Communication Services)
Equity, Since 30 Apr 19 | BHARTIARTL4% ₹72 Cr 348,551
↓ -3,779 Reliance Industries Ltd (Energy)
Equity, Since 30 Jun 24 | RELIANCE4% ₹67 Cr 447,851
↓ -4,855 Bharat Electronics Ltd (Industrials)
Equity, Since 31 Oct 19 | BEL4% ₹60 Cr 1,416,343
↓ -15,357 UltraTech Cement Ltd (Basic Materials)
Equity, Since 31 Mar 14 | 5325384% ₹59 Cr 49,239
↓ -533 GPT Infraprojects Ltd (Industrials)
Equity, Since 30 Nov 17 | GPTINFRA3% ₹51 Cr 4,733,244 InterGlobe Aviation Ltd (Industrials)
Equity, Since 31 Aug 24 | INDIGO3% ₹47 Cr 82,988
↓ -899 PTC India Financial Services Ltd (Financial Services)
Equity, Since 31 Dec 23 | PFS3% ₹45 Cr 12,400,122 Adani Ports & Special Economic Zone Ltd (Industrials)
Equity, Since 31 Dec 23 | ADANIPORTS3% ₹44 Cr 303,494
↓ -3,290
Research Highlights for Motilal Oswal Midcap 30 Fund